[Guidelines for diagnosis and management of drug-induced liver injury caused by anti-tuberculosis drugs (2024 version)].
Chinese Medical Association Tuberculosis Branch.
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Nov 12;47(11):1069-1090. doi: 10.3760/cma.j.cn112147-20240614-00338.
Differential HCC risk among HBV indeterminate types at baseline and by phase transition.
Huang R, Trinh HN, Yasuda S, Chau A, Maeda M, Do AT, Huang DQ, Ito T, Honda T, Ishigami M, Kozuka R, Preda CM, Tseng CH, Marciano S, Tsai PC, Lee DH, Wong CC, Do S, Kawashima K, Zhang J, Marin RI, Sandra I, Li J, Ogawa E, Cheung R, Li J, Yu ML, Gadano A, Hsu YC, Buti M, Enomoto M, Lim SG, Wu C, Toyoda H, Nguyen MH.
Gut. 2025 Oct 8;74(11):1873-1882. doi: 10.1136/gutjnl-2025-335033.
Natural history and prognostic factors for chronic hepatitis type B.
Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A.
Gut. 1991 Mar;32(3):294-8. doi: 10.1136/gut.32.3.294.
Morphological lesions detected by light and electron microscopies in chronic type B hepatitis.
Kasprzak A, Biczysko W, Adamek A, Zabel M.
Pol J Pathol. 2002;53(3):103-15.
Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ, Coelho-Little ME, Cheinquer H, Vargas C, Civantos F, Alvarez L, Reddy KR, Parker T, de Medina M, Li X, et al.
Am J Gastroenterol. 1995 Sep;90(9):1437-40.
Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis.
Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H.
J Gastroenterol Hepatol. 1998 Jul;13(7):680-4. doi: 10.1111/j.1440-1746.1998.tb00713.x.
Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
Zhou H, Wu X, Lu X, Chen G, Ye X, Huang J.
Thromb Res. 2009;123(3):537-42. doi: 10.1016/j.thromres.2008.06.013. Epub 2008 Aug 8.
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue TM Jr, Kharbanda KK, Cruz M, Opris M.
Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7.
Chronic hepatitis C infection: influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population.
Pereira LM, Spinelli V, Ximenes RA, Cavalcanti MS, Melo R, Jucá N, Mizokami M, McFarlane IG.
J Med Virol. 2002 May;67(1):27-32. doi: 10.1002/jmv.2188.
Therapy for hepatitis B virus infection.
Perrillo RP, Mason AL.
Gastroenterol Clin North Am. 1994 Sep;23(3):581-601.
